Notably, LGMN overexpression is correlated with aggressive tumor phenotypes and poor prognosis in colorectal and gastric cancers, whereas reduced LGMN expression has been linked to improved clinical outcomes [14,15]. Here, LGMN is linked to gastric cancer.